Literature DB >> 35034016

Effectiveness of Individual Cognitive-Behavioral Therapy and Predictors of Outcome in Adult Patients with Obsessive-Compulsive Disorder.

Norbert Kathmann1, Tanja Jacobi1, Björn Elsner1, Benedikt Reuter1.   

Abstract

INTRODUCTION: Cognitive-behavioral therapy (CBT) for obsessive-compulsive disorder (OCD) has proven its efficacy in randomized controlled trials (RCTs).
OBJECTIVE: To test generalizability to routine care settings, we conducted an effectiveness study to provide naturalistic outcome data and their predictors.
METHODS: Pre-post changes in symptoms and impairment as well as response rates were determined in a naturalistic OCD sample (intention-to-treat, ITT, n = 393). Patients received individual CBT for OCD adopting an exposure-based, non-manualized treatment format. Linear and logistic regression analyses were applied to identify associations of sociodemographic and clinical variables with symptom change.
RESULTS: Effect size in ITT patients amounted to d = 1.47 in primary outcome (Yale-Brown Obsessive-Compulsive Scale, Y-BOCS). Remission rates were 46.3% (ITT), 52.0% (completers), and 18.2% (non-completers). The rates of treatment response without remission, no change, and deterioration in the ITT sample were 13.2, 38, and 3%, respectively. Initial symptom severity, comorbid personality disorder, and unemployment were associated with a poorer outcome, and previous medication with a better outcome. Comorbid depressive and anxiety disorders as well as other clinical or sociodemographic variables showed no effects on symptom change.
CONCLUSIONS: Outcomes in this large observational trial in a naturalistic setting correspond to available RCT findings suggesting that CBT for OCD should be strongly recommended for dissemination in routine care. Targets for further research include early prediction of non-response and development of alternative treatment strategies for patients who respond insufficiently.
© 2022 S. Karger AG, Basel.

Entities:  

Keywords:  Cognitive-behavioral therapy; Effectiveness; Naturalistic setting; Obsessive-compulsive disorder; Outcome prediction

Mesh:

Year:  2022        PMID: 35034016     DOI: 10.1159/000520454

Source DB:  PubMed          Journal:  Psychother Psychosom        ISSN: 0033-3190            Impact factor:   17.659


  2 in total

Review 1.  [Treatment of obsessive-compulsive disorders: recommendations of the revised S3 guidelines on obsessive-compulsive disorders].

Authors:  Ulrich Voderholzer; Matthias Favreau; Antonie Rubart; Angelica Staniloiu; Andreas Wahl-Kordon; Bartosz Zurowski; Norbert Kathmann
Journal:  Nervenarzt       Date:  2022-06-28       Impact factor: 1.297

2.  Non-invasive brain stimulation modulates neural correlates of performance monitoring in patients with obsessive-compulsive disorder.

Authors:  Luisa Balzus; Julia Klawohn; Björn Elsner; Sein Schmidt; Stephan A Brandt; Norbert Kathmann
Journal:  Neuroimage Clin       Date:  2022-07-14       Impact factor: 4.891

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.